NM highlights. Census under-counting. Zip code cases. NM Volunteers needed. Jury trials suspended. Tracking NM cases. Tribal susceptibility & response. Shortages: Legal guidance. Life insurance pause. US case geography. Korean 2.1% reinfection. International policy review. Research disruption. Neuropsychiatric sequelae looming. Case undercounting. Antibody test utility. Air travel infection. FDA serologic test guidance. Household transmission. Human behavior & public health. Military leadership principles. Systematic review quality. Clozapine consensus. Guidelines for: nasopharyngeal swabs, tracheostomy, intubation, extubation, managing laryngectomy patients, stroke thrombectomy, cardiac surgery, neuroanesthesia, coagulopathy management, ECMO, radiology safety, nuclear medicine, gastroenterology, and grief in palliative care. Hydroxychloroquine and antivirals fail to show benefit. Review on drug repurposing. Viral load symptom onset. Lymphocytes & case severity. Reactive lymphocytes. Saliva testing. Blood test Dx alternative. RT-PCR + clinical suspicion. Sperm tests negative. Thrombocytopenia mechanisms. Smell dysfunction. No rhesus macaque reinfection. Respiratory center damage.
Lambert, Christophe G.; Shawn Stoicu; Ingrid Hendrix; Anastasiya Nestsiarovich; Praveen Kumar; Nicolas Lauve; Rachel D. King; Samuel Anyona; Evans Raballah; Cristian Bologa; Alexendra Yingling; Orrin Myers; Andrew S. Rowland; and Douglas J. Perkins. "2020-04-19 DAILY UNM GLOBAL HEALTH COVID-19 BRIEFING." (2020). https://digitalrepository.unm.edu/hsc_covid19_briefings/14